1. Targeting Glioblastoma Using a Novel Peptide Specific to a Deglycosylated Isoform of Brevican
- Author
-
Benjamin Scott, Sonja Bergmann, Marie Foley Kijewski, Charlotte E. Farquhar, Keith L. Ligon, Choi-Fong Cho, Mykola Zdioruk, Shuyan Wang, Sean E. Lawler, Mariano S. Viapiano, Leonard G. Luyt, Colin M. Fadzen, Bo Yeun Yang, Shipra Dubey, Martine L.M. Lamfers, Nina Hartrampf, E. Antonio Chiocca, Fernanda Bononi, Justin M. Wolfe, Marcelo F. DiCarli, Yarah Ghotmi, Bradley L. Pentelute, Niklas von Spreckelsen, J Roscoe Wasserburg, Emily Murrell, Neurosurgery, University of Zurich, Lawler, Sean E, and Cho, Choi‐Fong
- Subjects
10120 Department of Chemistry ,Gene isoform ,2716 Genetics (clinical) ,Glycosylation ,3003 Pharmaceutical Science ,Brain tumor ,Pharmaceutical Science ,Medicine (miscellaneous) ,Peptide ,2704 Biochemistry (medical) ,Article ,Extracellular matrix ,chemistry.chemical_compound ,SDG 3 - Good Health and Well-being ,Downregulation and upregulation ,Glioma ,540 Chemistry ,medicine ,2736 Pharmacology (medical) ,Pharmacology (medical) ,Brevican ,Genetics (clinical) ,Pharmacology ,chemistry.chemical_classification ,Biochemistry (medical) ,2701 Medicine (miscellaneous) ,medicine.disease ,nervous system diseases ,3004 Pharmacology ,chemistry ,Cancer research - Abstract
Glioblastoma (GBM) is the most common and deadliest form of brain tumor and remains amongst the most difficult cancers to treat. Brevican (Bcan), a central nervous system (CNS)-specific extracellular matrix protein, is upregulated in high-grade glioma cells, including GBM. A Bcan isoform lacking most glycosylation, dg-Bcan, is found only in GBM tissues. Here, dg-Bcan is explored as a molecular target for GBM. In this study, a d-peptide library is screened to identify a small 8-amino acid dg-Bcan-Targeting Peptide (BTP) candidate, called BTP-7 that binds dg-Bcan with high affinity and specificity. BTP-7 is preferentially internalized by dg-Bcan-expressing patient-derived GBM cells. To demonstrate GBM targeting, BTP-7 is radiolabeled with 18F, a radioisotope of fluorine, and increased radiotracer accumulation is found in intracranial GBM established in mice using positron emission tomography (PET) imaging. dg-Bcan is an attractive molecular target for GBM, and BTP-7 represents a promising lead candidate for further development into novel imaging agents and targeted therapeutics.
- Published
- 2021
- Full Text
- View/download PDF